-
Posted by
Two Blokes Jun 16 -
Filed in
Stock
-
5 views
SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) securities between February 7, 2025 and May 26, 2025.Rocket is a fully integrated, late-stage biotechnology company focused on the development of gene therapies, with direct on-target mechanism of action and clear clinical endpoints, for rare and devastating diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
